Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date01 Sep 1999 |
100 Clinical Results associated with Paladin Pharma SpA
0 Patents (Medical) associated with Paladin Pharma SpA
100 Deals associated with Paladin Pharma SpA
100 Translational Medicine associated with Paladin Pharma SpA